Meta-analysis confirms miR-21 expression, laryngeal CA link

December 22, 2015
Meta-analysis confirms miR-21 expression, laryngeal CA link

(HealthDay)—Expression of miR-21 is associated with laryngeal carcinoma, with high expression related to increased laryngeal cancer risk, according to a meta-analysis published online Dec. 12 in the Journal of Evidence-Based Medicine.

Peng Zhou, M.D., from the West China Hospital at Sichuan University, and colleagues conducted a meta-analysis to examine the expression and clinical significance of miR-21 in tissues of laryngeal carcinoma. Data were reviewed from four studies with 160 cases.

The researchers observed no significant between-study heterogeneity. Meta-analyses showed that there was high miR-21 expression in laryngeal cancer versus non-neoplasm tissue (odds ratio, 4.47; P = 0.02). Expression of miR-21 between TMN I-II and TMN III-IV was reported in only one study.

"In conclusion, the expression of miR-21 correlative laryngeal carcinoma is confirmed. It suggests that high expression of miR-21 may be related with laryngeal cancer risk," the authors write. "The miR-21 expression level might be an important biological marker of diagnosis. Nonetheless, large and well-designed prospective studies should be conducted to confirm these findings before miR-21 can be implemented into routine clinical management."

Explore further: H. pylori linked to increased odds of laryngeal carcinoma

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

H. pylori linked to increased odds of laryngeal carcinoma

September 16, 2015
(HealthDay)—Helicobacter pylori (H. pylori) infection is associated with significantly increased odds of laryngeal carcinoma but not pharyngeal cancer, according to a review published online Aug. 28 in Head & Neck.

Serum miR-21 putative biomarker for colorectal cancer

June 20, 2013
(HealthDay)—The oncogenic microRNA (miRNA) miR-21 is a potential biomarker for detection and prognosis of colorectal cancer (CRC), according to a study published in the June 19 issue of the Journal of the National Cancer ...

miR-7 suppresses stomach cancer

August 10, 2015
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium ...

Prognostic role found for miR-21 expression in triple-negative breast cancer

December 2, 2014
"Triple-negative" breast cancer (TNBC) occurs in patients whose cells do not express receptors for estrogen, progesterone, and/or human epidermal growth factor receptor 2 (ER-/PR-/HER2-). Because of the absence of these predictive ...

Biomarker helps predict survival time in gastric cancer patients

September 8, 2015
Gastric cancer poses a significant health problem in developing countries and is typically associated with late-stage diagnosis and high mortality. A new study in The American Journal of Pathology points to a pivotal role ...

Recommended for you

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

NEJM reports positive results for larotrectinib against TRK-fusion cancer

February 22, 2018
In 2013, the labs of University of Colorado Cancer Center investigator Robert C. Doebele, MD, PhD, and Dana-Farber Cancer Institute investigator Pasi A. Jänne, MD, PhD reported in Nature Medicine the presence of TRK gene ...

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

New therapeutic gel shows promise against cancerous tumors

February 21, 2018
Scientists at the UNC School of Medicine and NC State have created an injectable gel-like scaffold that can hold combination chemo-immunotherapeutic drugs and deliver them locally to tumors in a sequential manner. The results ...

Kinase inhibitor larotrectinib shows durable anti-tumor abilities

February 21, 2018
Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses. All patients had tumors ...

Five novel genetic changes linked to pancreatic cancer risk

February 21, 2018
In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.